Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 10 IN PLASTIC CONTAINER versus NORMOSOL R IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 10 IN PLASTIC CONTAINER versus NORMOSOL R IN PLASTIC CONTAINER.
DEXTROSE 10% IN PLASTIC CONTAINER vs NORMOSOL-R IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Intravenous dextrose provides a source of calories and water for hydration. Dextrose is metabolized to carbon dioxide and water, yielding energy (approximately 3.4 kcal/g). It also stimulates insulin secretion and promotes glycogen synthesis.
Normosol-R is an isotonic crystalloid solution that replaces extracellular fluid volume and electrolytes. It provides sodium, chloride, potassium, magnesium, acetate, and gluconate to maintain acid-base balance and osmotic equilibrium. Acetate and gluconate are metabolized to bicarbonate, providing an alkalinizing effect.
Intravenous infusion, 500-1000 mL (50-100 g dextrose) as a single dose, rate determined by clinical condition; typical maintenance 100-125 mL/h.
Intravenous infusion; dose determined by electrolyte and fluid requirements; typical adult dose: 250-1000 mL/hour, not to exceed 30 mL/kg/day.
None Documented
None Documented
The metabolic half-life of glucose is 1.5–2.5 hours; however, the plasma half-life of infused dextrose is approximately 1.5–2 hours, with clinical context indicating that doses >0.5 g/kg/hour can exceed oxidative capacity, leading to hyperglycemia.
Not applicable as a drug; the half-life of infused crystalloid components is distribution-dependent. Sodium and chloride have a terminal half-life of approximately 2-4 hours in healthy adults, reflecting renal clearance. Clinical context: Half-life prolonged in renal impairment.
Glucose is primarily metabolized via glycolysis and oxidative phosphorylation to CO2 and water; less than 5% is excreted unchanged in urine under normal conditions. In hyperglycemia with glycosuria, up to 50% may be lost renally.
Renal excretion of electrolytes and water; no hepatic metabolism. >95% of administered water and electrolytes are excreted renally, with small amounts lost via feces (<2%) and insensible losses.
Category C
Category C
Intravenous Fluid
Intravenous Fluid/Electrolyte Solution